Ortho Tri-Cyclen Lo, associated with the barcode 300621251004, is an oral contraceptive produced by Ortho Pharmaceutical Corporation. Below are the details regarding this product:
Key Information
- Product Name: Ortho Tri-Cyclen Lo
- Manufacturer: Ortho Pharmaceutical Corporation
- Package Size: 28 tablets
- Active Ingredients:
- Levonorgestrel: 0.15 mg
- Ethinyl Estradiol: 20 µg
Indications
Ortho Tri-Cyclen Lo is primarily indicated for the prevention of pregnancy as it is an oral contraceptive.
Contraindications
There are specific conditions under which this medication should not be used, including:
- History of breast cancer
- Current or past blood clots
- Uncontrolled high blood pressure
- Liver disease
- Smoking, particularly in women over 35
- Certain surgical procedures which may increase the risk of thrombosis
Warnings and Concerns
Utilizing estrogen-containing contraceptives like Ortho Tri-Cyclen Lo carries certain risks:
- Increased Risk of Blood Clots: There is a notable increase in the risk of venous thromboembolism (blood clots) when using contraceptives that contain estrogen.
- Liver Damage Risks: Patients with preexisting liver conditions may face severe liver damage while using this medication.
- Cardiovascular Risks: Smoking can significantly elevate the risk of serious cardiovascular events, particularly when combined with hormonal contraceptives.
Pricing Information
The price for Ortho Tri-Cyclen Lo can vary based on factors such as location, pharmacy, and insurance coverage. Estimates are as follows:
- Without insurance: Typically ranges from $20 to $40 for a 28-tablet pack.
- With insurance: The cost may reduce to approximately $10 to $20, depending on individual plans and copays.
Health Disclaimer
As a consumable pharmaceutical product, it’s essential to consult with a healthcare provider before use. Individual health factors must be considered before starting any new medication.
This product's information is subject to change, and it’s advisable to check with healthcare providers or pharmacists for the most current guidance and recommendations.